Testing effectiveness (Phase 2)Study completedNCT04138056
What this trial is testing
A Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Diphtheria, Pertussis and Tetanus (Tdap) Viruses Followed by a 2nd Dose of the RSV Vaccine to Healthy Non-Pregnant Women
Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 509